🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. Shexiang Baoxin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  2. Shexiang Baoxin pill（MUSKARDIA）

    Disc Medicine

    Ischemia With Non-Obstructive Coronary Artery

    approved other completed

    1 trial

  3. Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Herpes Zoster

    approved small molecule active

    1 trial

  4. Short Cycle Antiretroviral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other completed

    1 trial

  5. Silver Sulfadiazine

    United Therapeutics Europe Ltd

    Superficial Partial Thickness Burn

    approved small molecule terminated

    1 trial

  6. Sitagliptin

    Chen Suning

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  7. Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets

    The George Institute

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  8. Skin stretching device (SSD)

    The First People's Hospital of Lianyungang

    Trauma

    approved other active

    1 trial

  9. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  10. Sodium Chloride Fresenius Kabi Italia 0,9 % Solution for infusion, MabThera 500 mg concentrate for solution for infusion

    Disc Medicine

    Systemic sclerosis

    approved small molecule active

    1 trial

  11. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  12. Sofosbuvir/velpatasvir (Epclusa®)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  13. Softacort 3,35 mg/ml colirio en solución en envases unidosis

    Laboratorios Tillomed Spain S.L.U

    Dry Eye and Meibomian Gland Dysfunction

    approved small molecule active

    1 trial

  14. Solriamfetol

    Axsome Therapeutics

    Excessive Daytime Sleepiness

    approved small molecule completed

    1 trial

  15. Solriamfetol 75 MG

    Axsome Therapeutics

    Insomnia

    approved small molecule completed

    1 trial

  16. Solriamfetol Oral Tablet

    Axsome Therapeutics

    Excessive Sleepiness

    approved small molecule terminated

    1 trial

  17. Sovaldi 400 mg film-coated tablets

    Disc Medicine

    Healthy volunteers

    approved small molecule active

    1 trial

  18. Sparsentan

    Travere Therapeutics

    Proteinuria

    approved small molecule active

    1 trial

  19. Spesolimab

    Boehringer Ingelheim

    Generalized Pustular Psoriasis

    approved small molecule active

    3 trials

  20. Standard BP control

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  21. Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum

    United Therapeutics Europe Ltd

    Frostbite

    approved small molecule active

    1 trial

  22. Statin

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  23. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial

  24. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources